Skip to content
Advertisement

FILE - This Feb. 19, 2013 file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. On Friday, Sept. 11, 2020, a U.S. Food and Drug Administration advisory panel said there’s no clear evidence that a reformulated version of the painkiller OxyContin designed to discourage abuse actually resulted in fewer overdoses or cases of addiction. (AP Photo/Toby Talbot, File)

FILE - This Feb. 19, 2013 file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. On Friday, Sept. 11, 2020, a U.S. Food and Drug Administration advisory panel said there’s no clear evidence that a reformulated version of the painkiller OxyContin designed to discourage abuse actually resulted in fewer overdoses or cases of addiction. (AP Photo/Toby Talbot, File)

Featured Photo Galleries